Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 145 entries
View as:

A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05345938 Org: User:
Start: 06/14/22 End: 11/19/22 Due: 11/19/23

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05055791 Org: User:
Start: 12/29/21 End: 09/20/26 Due: 09/20/27

A Study To Evaluate the Safety, Tolerance, Pharmacokinetics/Pharmacodynamics and Efficacy of SYHA1402 Tablets For the Treatment of Patients With Diabetic Peripheral Neuropathy in China

Phase: N/A Priority: Normal
NCT ID: NCT05116111 Org: User:
Start: 12/31/21 End: 06/15/23 Due: 06/15/24

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04718402 Org: User:
Start: 03/30/21 End: 05/30/22 Due: 05/30/23

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of SYHA1402 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04453618 Org: User:
Start: 08/31/20 End: 12/31/20 Due: 12/31/21

Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)

Phase: N/A Priority: Normal
NCT ID: NCT05715840 Org: User:
Start: 01/31/23 End: 05/31/26 Due: 05/31/27

SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT05445154 Org: User:
Start: 08/31/21 End: 12/31/26 Due: 12/31/27

Study of Desvenlafaxine in Treating Major Depressive Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT04364997 Org: User:
Start: 06/18/20 End: 09/22/21 Due: 09/22/22

Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets

Phase: N/A Priority: Normal
NCT ID: NCT03420534 Org: User:
Start: 11/17/17 End: 03/14/18 Due: 03/14/19

Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02595242 Org: User:
Start: 06/30/15 End: 06/30/17 Due: 06/30/18

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04718376 Org: User:
Start: 01/12/21 End: 05/22/23 Due: 05/22/24

Study of DP303c Administered Intravenously to Subjects With HER2-Positive in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04146610 Org: User:
Start: 11/30/19 End: 06/30/21 Due: 06/30/22

Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL

Phase: N/A Priority: Normal
NCT ID: NCT04509466 Org: User:
Start: 09/15/20 End: 01/30/22 Due: 01/30/23

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.

Phase: N/A Priority: Normal
NCT ID: NCT05354063 Org: User:
Start: 06/01/22 End: 10/01/23 Due: 10/01/24

Study of HA121-28 in Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05117658 Org: User:
Start: 02/18/22 End: 10/31/23 Due: 10/31/24

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04859439 Org: User:
Start: 06/15/21 End: 12/31/21 Due: 12/31/22

A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05125523 Org: User:
Start: 12/28/21 End: 11/30/24 Due: 11/30/25

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05863325 Org: User:
Start: 06/27/23 End: 09/30/24 Due: 09/30/25

A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT05100303 Org: User:
Start: 12/31/21 End: 06/30/23 Due: 06/30/24

Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06947291 Org: User:
Start: 04/30/25 End: 10/30/27 Due: 10/30/28

Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02059785 Org: User:
Start: 06/30/13 End: 12/31/16 Due: 12/31/17

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05508620 Org: User:
Start: 10/31/22 End: 12/31/24 Due: 12/31/25

Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03940183 Org: User:
Start: 07/08/19 End: 12/28/20 Due: 12/28/21

Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

Phase: N/A Priority: Normal
NCT ID: NCT05018013 Org: User:
Start: 08/21/21 End: 12/30/22 Due: 12/30/23

A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04900766 Org: User:
Start: 08/11/21 End: 02/03/23 Due: 02/03/24